Лучшие подкасты про Pvi (2024)

1
PvI#83: Half Philosophizing (Season 4 Premiere) 56:19

13h ago56:19

56:19

Welcome to the beginning of a new round of shenanigans on Philosophy vs. Improv. Let the senior slump begin! Your hosts Mark Linsenmayer and Bill Arnett here talk a blazin' stream of consciousness and then have a pretty long improv scene. Are we already always philosophizing? Watch the proceedings unedited on YouTube. Learn more about your ad choic…

1
PEL Presents PvI#82: LIVE in Personability w/ James Whittington 52:57

27d ago52:57

52:57

Chicago's iO Theater was graced on August 21 by Mark, Bill, and special guest theater educator James Whittington, who spoke about embodiment (see Maurice Merleau-Ponty), the possible disconnect between meaning and tone, and being in the physical presence of greatness. They acted out scenes (while still sitting!) about an unsuccessful party and Expe…

1
PvI#82: LIVE in Personability w/ James Whittington

27d ago

—

Chicago's iO Theater was graced on August 21 by Mark, Bill, and special guest theater educator James Whittington, who spoke about embodiment (see Maurice Merleau-Ponty), the possible disconnect between meaning and tone, and being in the physical presence of greatness. They acted out scenes (while still sitting!) about an unsuccessful party and Expe…

1
Philosophy vs. Improv #83: Half Philosophizing (Season 4 Premiere)

11h ago

—

Welcome to the beginning of a new round of shenanigans on Philosophy vs. Improv. Let the senior slump begin! Your hosts Mark Linsenmayer and Bill Arnett here talk a blazin' stream of consciousness and then have a pretty long improv scene. Are we already always philosophizing? Watch the proceedings unedited on YouTube. Hear more at philosophyimprov.…

1
Pretty Much Pop #182: Tim Burton: Shtick Macabre

4d ago

—

In light of the new Beetlejuice Beetlejuice, we discuss the films of director (and occasional writer) Tim Burton since his career was firmly established by his early work in the '80s including the original 1988 Beetlejuice. Mark, Lawrence, Sarahlyn, and Al have very mixed reactions to the new film, but we agree that the animation style that charact…

1
Ep. 352: Thomas Reid on Smelling and Knowledge (Part Two) 49:20

4d ago49:20

49:20

Continuing on Inquiry into the Human Mind, getting further into the chapter on smelling as well as the conclusion and Reid's exchange with Hume. What exactly is our relation with objects in the world according to Reid? Get more at partiallyexaminedlife.com. Visit partiallyexaminedlife.com/support to get ad-free episodes and bonus content.…

1
Ep. 352: Thomas Reid on Smelling and Knowledge (Part Two) 49:21

3d ago49:21

49:21

Continuing on Inquiry into the Human Mind, getting further into the chapter on smelling as well as the conclusion and Reid's exchange with Hume. What exactly is our relation with objects in the world according to Reid? Get more at partiallyexaminedlife.com. Visit partiallyexaminedlife.com/support to get ad-free episodes and bonus content.…

1
Ep. 352: Thomas Reid on Smelling and Knowledge (Part Two)

4d ago

—

Subscribe to get parts 1 and 2 of this now, ad-free, plus tons of bonus content. Continuing on Inquiry into the Human Mind, getting further into the chapter on smelling as well as the conclusion and Reid's exchange with Hume. What exactly is our relation with objects in the world according to Reid? The post Ep. 352: Thomas Reid on Smelling and Know…

1
Love Dishonored in Euripides' "Medea" - Part 6 50:17

5d ago50:17

50:17

Wes & Erin continue their discussion of Ancient Greece’s most notorious battle of the sexes, and Euripides’ rumination on the question of whether the Athenian ideals of rationality and moderation sufficiently honor the instinctual side of human nature.Mark Linsenmayer

1
PEL Presents SUBTEXT: Love Dishonored in Euripides' "Medea" - Part 6 1:03:22

5d ago1:03:22

1:03:22

Wes & Erin continue their discussion of Ancient Greece’s most notorious battle of the sexes, and Euripides’ rumination on the question of whether the Athenian ideals of rationality and moderation sufficiently honor the instinctual side of human nature. To hear all the previous parts of this, just go check out subtextpodcast.com.…

1
Ep. 352: Thomas Reid on Smelling and Knowledge (Part One) 55:14

11d ago55:14

55:14

On Inquiry into the Human Mind on the Principles of Common Sense (1764): the introduction, conclusion, ch. 2 "Of Smelling" ch. 4 "Of Hearing," and some correspondence between Reid and Hume. According to Reid, the big mistake of "modern" philosophy is thinking that objects in the world need to resemble the sensations we have of them. Smelling is sup…

1
Ep. 352: Thomas Reid on Smelling and Knowledge (Part One) 55:15

11d ago55:15

55:15

On Inquiry into the Human Mind on the Principles of Common Sense (1764): the introduction, conclusion, ch. 2 "Of Smelling" ch. 4 "Of Hearing," and some correspondence between Reid and Hume. According to Reid, the big mistake of "modern" philosophy is thinking that objects in the world need to resemble the sensations we have of them. Smelling is sup…

1
Ep. 352: Thomas Reid on Smelling and Knowledge (Part One)

11d ago

—

Subscribe to get parts 1 and 2 of this now, ad-free, plus tons of bonus content. On Inquiry into the Human Mind on the Principles of Common Sense (1764): the introduction, conclusion, ch. 2 "Of Smelling" ch. 4 "Of Hearing," and some correspondence between Reid and Hume. According to Reid, the big mistake of "modern" philosophy is thinking that obje…

1
PEL Presents PMP#182: Tim Burton: Shtick Macabre 51:13

11d ago51:13

51:13

In light of the new Beetlejuice Beetlejuice, we discuss the films of director (and occasional writer) Tim Burton since his career was firmly established by his early work in the '80s including the original 1988 Beetlejuice. Mark, Lawrence, Sarahlyn, and Al have very mixed reactions to the new film, but we agree that the animation style that charact…

1
PEL Presents PMP#182: Tim Burton: Shtick Macabre 51:46

11d ago51:46

51:46

In light of the new Beetlejuice Beetlejuice, we discuss the films of director (and occasional writer) Tim Burton since his career was firmly established by his early work in the '80s including the original 1988 Beetlejuice. Mark, Lawrence, Sarahlyn, and Al have very mixed reactions to the new film, but we agree that the animation style that charact…

1
PREMIUM-Ep. 351: Sophie Grace Chappell on Transgender (Part Two) 14:41

12d ago14:41

14:41

Mark, Seth and Dylan continue talking about philosophy surrounding trans phenomena in light of our interview with Sophie Grace about Trans Figured. In this supporter-exclusive discussion, we get into sex and gender as cluster concepts, ethical theory in equity discussions, and the practical matters you'd expect: sports participation, pronouns, bath…

1
PREMIUM-Ep. 351: Sophie Grace Chappell on Transgender (Part Two) 13:42

12d ago13:42

13:42

Mark, Seth and Dylan continue talking about philosophy surrounding trans phenomena in light of our interview with Sophie Grace about Trans Figured. In this supporter-exclusive discussion, we get into sex and gender as cluster concepts, ethical theory in equity discussions, and the practical matters you'd expect: sports participation, pronouns, bath…

1
William G. Wierda, MD, PhD - Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care 58:41

5d ago58:41

58:41

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/THK865. CM…

1
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:59

13d ago55:59

55:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/BVU865. EBAC/CME c…

1
William G. Wierda, MD, PhD - Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care 58:41

5d ago58:41

58:41

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/THK865. CM…

1
William G. Wierda, MD, PhD - Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care 58:41

11d ago58:41

58:41

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/THK865. CM…

1
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:59

13d ago55:59

55:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/BVU865. EBAC/CME c…

1
Taofeek K. Owonikoko, MD, PhD - Taking a BiTE Out of SCLC: Are You Ready for a New Wave of DLL3-Targeting T-Cell Engagers and Other Therapies? 30:52

7d ago30:52

30:52

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/RHX865. CME/AAPA c…

1
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:58

13d ago55:58

55:58

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/BVU865. EBAC/CME c…

1
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:58

13d ago55:58

55:58

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/BVU865. EBAC/CME c…

1
Taofeek K. Owonikoko, MD, PhD - Taking a BiTE Out of SCLC: Are You Ready for a New Wave of DLL3-Targeting T-Cell Engagers and Other Therapies? 30:52

7d ago30:52

30:52

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/RHX865. CME/AAPA c…

1
Taofeek K. Owonikoko, MD, PhD - Taking a BiTE Out of SCLC: Are You Ready for a New Wave of DLL3-Targeting T-Cell Engagers and Other Therapies? 30:52

13d ago30:52

30:52

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/RHX865. CME/AAPA c…

1
William G. Wierda, MD, PhD - Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care 58:41

7d ago58:41

58:41

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/THK865. CM…

1
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:59

13d ago55:59

55:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/BVU865. EBAC/CME c…

1
Taofeek K. Owonikoko, MD, PhD - Taking a BiTE Out of SCLC: Are You Ready for a New Wave of DLL3-Targeting T-Cell Engagers and Other Therapies? 30:52

6d ago30:52

30:52

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/RHX865. CME/AAPA c…

1
Taofeek K. Owonikoko, MD, PhD - Taking a BiTE Out of SCLC: Are You Ready for a New Wave of DLL3-Targeting T-Cell Engagers and Other Therapies? 30:52

9d ago30:52

30:52

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/RHX865. CME/AAPA c…

1
Stephen Salloway, MD, MS, Sharon J. Sha, MD, MS - Keeping PACE™ in Alzheimer’s Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment 55:26

13d ago55:26

55:26

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JNE865. C…

1
Stephen Salloway, MD, MS, Sharon J. Sha, MD, MS - Keeping PACE™ in Alzheimer’s Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment 55:26

13d ago55:26

55:26

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JNE865. C…

1
Stephen Salloway, MD, MS, Sharon J. Sha, MD, MS - Keeping PACE™ in Alzheimer’s Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment 55:26

13d ago55:26

55:26

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JNE865. C…

1
Stephen Salloway, MD, MS, Sharon J. Sha, MD, MS - Keeping PACE™ in Alzheimer’s Disease: Precision Strategies to Achieve Early Diagnosis and Safely Integrate Disease-Modifying Treatment 55:26

13d ago55:26

55:26

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/JNE865. C…

1
Taofeek K. Owonikoko, MD, PhD - Taking a BiTE Out of SCLC: Are You Ready for a New Wave of DLL3-Targeting T-Cell Engagers and Other Therapies? 30:52

13d ago30:52

30:52

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/RHX865. CME/AAPA c…

1
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:58

13d ago55:58

55:58

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/BVU865. EBAC/CME c…

1
Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:59

13d ago55:59

55:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/BVU865. EBAC/CME c…

Подкасты, которые стоит послушать

Подкасты на тему Pvi

Подкасты, которые стоит послушать

Краткое руководство